U.S. private equity firm Bain Capital said it may withdraw its tender offer proposal for Japanese IT firm Fuji Soft, after ...

Bain Capital may withdraw tender offer for Fuji Soft, after KKR raised bid in intense bidding war. Global investors target ...

Bain Capital is considering withdrawing its tender offer for Japanese IT firm Fuji Soft after rival U.S. private equity giant ...

Bain Capital disclosed that it is considering the "option of withdrawing" its hostile $4.2 billion takeover bid for Japanese ...

TOKYO -- The jockeying to acquire Fuji Soft has exposed a hole in Japanese tender offer regulations that has allowed Bain Capital to vie with fellow U.S.-based private equity firm KKR without going ...

Increased tender offer price aims to resolve uncertainty around FUJI SOFT’s privatization and enable KKR to focus on value creation efforts alongside the Company post privatization KKR ...

U.S. investment fund Bain Capital may not launch a tender offer for Japanese system developer Fuji Soft Inc., it has been ...

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Tanabe Pharma focuses on therapeutic areas such as immunology and inflammation, vaccines, diabetes, and central nervous ...